Answers are grounded in this paper and cite their sources.
Aging is a complex biological process influenced by genetic, environmental, and lifestyle factors. Natural bioactive compounds are increasingly recognized as potential anti-aging agents. Ageratum conyzoides is a medicinal herb enriched with flavonoids, terpenoids, and sterols, which may contribute to its therapeutic potential. In this study, bioactive compounds derived from Ageratum conyzoides targeting G protein-coupled receptors (GPCRs) implicated in aging-related mechanisms were investigated using computational approaches. Molecular docking analysis was employed to evaluate forty phytochemicals against the β2-adrenergic receptor, angiotensin II type 1 (AT1) receptor, and adenosine A2A receptor. Several compounds demonstrated strong binding affinities, includingquercetin-3,7-diglucoside (−10.0 kcal/mol), friedelin (−9.0 kcal/mol), and stigmasterol (−10.3 kcal/mol). These findings suggest that Ageratum conyzoides contains potential ligand candidates capable of modulating G protein-coupled receptors involved in aging-related pathways. To establish biological relevance, further validation through molecular dynamics simulations and experimental studies is warranted.
No takes yet. Share an insight, caveat, or question.
Yustian et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: